Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion type Assertion NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_head.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion description "[We hypothesized that treatment with EGb-761 would increase serum BDNF levels and reduce TD, particularly among schizophrenia patients who have the BDNF valine 66 to methionine (Val66Met) genotype (Val/Val).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_provenance.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion evidence source_evidence_literature NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_provenance.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion SIO_000772 22695185 NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_provenance.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion wasDerivedFrom befree-20140225 NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_provenance.
- NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_assertion wasGeneratedBy ECO_0000203 NP208846.RA3gN2JwtIOLZJNpg3EGAViYGeSbW5KqWszAISmryo0uM130_provenance.